Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Creating a Product Portfolio from the Ground Up

June 1, 2012

Mike Clayman, CEO of Flexion Therapeutics, talks about his company's strategy to focus on a single therapeutic area.

Determining Process Quality Metrics for CMOs

June 1, 2012

Implementing quality by design makes the determination of quality metrics across CMOs and sponsors essential.

Some Supply Chain Lessons Can Go a Long Way

May 1, 2012

No matter the time or cost, knowing what's going on inside your facilities is always going to be worth the effort.

FDA Explores Options to Expand Access to NonPrescription Drugs

May 1, 2012

Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.

Changing Your Business Model

May 1, 2012

BioPharm talks with Tarja Mottram, CEO of Action for Results, on design-for-value concepts, management, and cross-functionality.

Channeling Steve Jobs

May 1, 2012

Service providers must focus on delivering a superior customer experience.

A New Way to Think About Outsourcing Partnerships

May 1, 2012

Future sponsor-contract provider relationships will require more integration.

A 25-Year Retrospective on the Biotech Business

May 1, 2012

This month, we rewind to an article titled "The Biotechnology Industry: A First Quarter Snapshot."

How to Respond to Consent Decrees

May 1, 2012

How to handle and respond to a consent decree.

ADVERTISEMENT

ADVERTISEMENT

Click here